DEXUVE
Live / Registered — Registered (as of 15 Dec 2020)
What this means for you
Registered since 15 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79261531
- Registration number
- 6218841
- Mark type
- Stylized text
- Filed
- 16 May 2019
- Published for opposition
- 29 Sept 2020
- Registered
- 15 Dec 2020
- Attorney of record
- Merilee J. Arevalo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner
Prosecution history
- 15 Dec 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 27 Jun 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Jul 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 12 Apr 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Mar 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Mar 2021 — FINAL DISPOSITION PROCESSED
- 15 Mar 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 19 Dec 2020 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 15 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 02 Dec 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 02 Dec 2020 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 29 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Sept 2020 — PUBLISHED FOR OPPOSITION
- 09 Sept 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER